Loading data
PGENNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.68 m USD | 3.93 m USD | 6.23 m USD | 26.91 m USD | 14.27 m USD |
| Research and development expense | 41.33 m USD | 53.07 m USD | 48.61 m USD | — | — |
| Selling, general and administrative expense | 70.13 m USD | 41.29 m USD | 40.42 m USD | — | — |
| Operating profit | -110.51 m USD | -135.03 m USD | -99.76 m USD | — | — |
| Profit before tax | -250.64 m USD | -128.03 m USD | -96.36 m USD | -79.97 m USD | -110.97 m USD |
| Income tax expense | 3 k USD | -1.79 m USD | -458 k USD | -189 k USD | -160 k USD |
| Net income (reported basis) | -250.6 m USD | -126.2 m USD | -95.9 m USD | 28.3 m USD | -92.2 m USD |
| Net income attributable to common shareholders | -429.64 m USD | -126.24 m USD | -95.9 m USD | — | — |
| Basic earnings per share | -1.37 USD/share | -0.47 USD/share | -0.39 USD/share | 0.14 USD/share | -0.47 USD/share |
| Diluted earnings per share | -1.37 USD/share | -0.47 USD/share | -0.39 USD/share | 0.14 USD/share | -0.47 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.